Clinical Challenges: JAK Inhibitors for Atopic Dermatitis | MedPage Today

Eichenfield, MD, of the University of California San Diego in La Jolla, told MedPage Today. Dupilumab, an interleukin (IL)-4/IL-13-directed …

Do you trust this headline?

You already voted!